David C. Paul - 23 Jan 2025 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
Executive Chairman, Director, 10%+ Owner
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Issuer symbol
GMED
Transactions as of
23 Jan 2025
Transactions value $
$0
Form type
4
Date filed
28 Mar 2025, 19:04
Previous filing
20 Nov 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Award $0 +75K $0.00 75K 23 Jan 2025 Class A Common Stock 75K $92.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on January 23, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.